Genomics and bioinformatics of Parkinson's disease

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 7, 2012, Pages

  Scholz, Sonja W ^a   Mhyre, Tim ^a   Ressom, Habtom ^b   Shah, Salim ^a   Federoff, Howard J ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MICRORNA; SMALL INTERFERING RNA; BIOLOGICAL MARKER; PROTEOME; TRANSCRIPTOME;

ALZHEIMER DISEASE; ARTICLE; BIOINFORMATICS; CHROMOSOME 19; DNA METHYLATION; DNA SEQUENCE; DRUG DESIGN; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMICS; GENOTYPING TECHNIQUE; HUMAN; HUMAN GENOME; MULTIFACTOR DIMENSIONALITY REDUCTION; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PLURIPOTENT STEM CELL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SEQUENCE ANALYSIS; SERIAL ANALYSIS OF GENE EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; DRUG DEVELOPMENT; GENETICS; METABOLOME; REVIEW; TRANSLATIONAL RESEARCH;

BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; METABOLOME; PARKINSON DISEASE; PROTEOME; TRANSCRIPTOME; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84879091554     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a009449     Document Type: Article

References (70)

1. Amit I, Garber M, Chevrier N, Leite AP, Donner Y, Eisenhaure T, Guttman M, Grenier JK, Li W, Zuk O, et al. 2009. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326: 257-263.
2. Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, et al. 2009. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 15: 441-451.
3. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, DekkerMC, Squitieri F, Ibanez P, Joosse M, et al. 2003. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259.
4. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. 2002. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249: III/1-5.
5. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. 2003a. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211.
6. Braak H, Rub U, Gai WP, Del Tredici K. 2003b. Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110: 517-536.
7. Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J. 2010. Using "omics" to define pathogenesis and biomarkers of Parkinson's disease. Expert Rev Neurother 10: 925-942.
8. Cerami E, Demir E, Schultz N, Taylor BS, Sander C. 2010. Automated network analysis identifies core pathways in glioblastoma. PLoS ONE 5: e8918.
9. Chang JT, Carvalho C, Mori S, Bild AH, Gatza ML, Wang Q, Lucas JE, Potti A, Febbo PG, West M, et al. 2009. A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell 34: 104-114.
10. Chen J, Sam L, Huang Y, Lee Y, Li J, Liu Y, Xing HR, Lussier YA. 2010. Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures. J Biomed Inform 43: 385-396.
11. Chien CH, Sun YM, Chang WC, Chiang-Hsieh PY, Lee TY, Tsai WC, Horng JT, Tsou AP, Huang HD. 2011. Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res 392: 9345-9356.
12. Cooper O, Hargus G, Deleidi M, Blak A, Osborn T, Marlow E, Lee K, Levy A, Perez-Torres E, Yow A, et al. 2010. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci 45: 258-266.
13. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, et al. 2011. Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Res 39: D691-D697.
14. Dauer W, Przedborski S. 2003. Parkinson's disease: Mechanisms and models. Neuron 39: 889-909.
15. Dawson TM, Dawson VL. 2003. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822.
16. Edwards YJ, Beecham GW, Scott WK, Khuri S, Bademci G, Tekin D, Martin ER, Jiang Z, Mash DC, ffrench-Mullen J, et al. 2011. Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS ONE 6: e16917.
17. Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. 2001. α-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 10: 1847-1851.
18. Feany MB, Bender WW. 2000. A Drosophila model of Parkinson's disease. Nature 404: 394-398.
19. Gatza ML, Lucas JE, Barry WT, Kim JW, Wang Q, Crawford MD, Datto MB, KelleyM, Mathey-Prevot B, Potti A, et al. 2010. A pathway-based classification of human breast cancer. Proc Natl Acad Sci 107: 6994-6999.
20. Hastie T, Tibshirani R, Friedman J. 2009. The elements of statistical learning: Data mining, inference, and prediction, 2nd ed. Springer, New York.
21. Hawkes CH, Del Tredici K, Braak H. 2010. A timeline for Parkinson's disease. Parkinsonism Relat Disord 16: 79-84.
22. Hu Z, Hung JH, Wang Y, Chang YC, Huang CL, Huyck M, DeLisi C. 2009. VisANT 3. 5: Multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Res 37: W115-W121.
23. Imming P, Sinning C, Meyer A. 2006. Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov 5: 821-834.
24. International HapMap Consortium. 2005. Haplotype map of the human genome. Nature 437: 1299-1320.
25. International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simón-Sánchez J, Schulte C, Lesage S, et al. 2011. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: A meta-analysis of genome-wide association studies. Lancet 377: 641-649.
26. International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2). 2011. A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 7: e1002142.
27. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-D280.
28. Kim TY, Kim HU, Lee SY. 2010. Data integration and analysis of biological networks. Curr Opin Biotechnol 21: 78-84.
29. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. 1998. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608.
30. Kreeger PK, Lauffenburger DA. 2010. Cancer systems biology: A network modeling perspective. Carcinogenesis 31: 2-8.
31. Lander ES. 2011. Initial impact of the sequencing of the human genome. Nature 470: 187-197.
32. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
33. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, et al. 2009. Finding the missing heritability of complex diseases. Nature 461: 747-753.
34. Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Kruger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, et al. 2006. Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease. JAMA296: 661-670.
35. Mardis ER. 2006. Anticipating the 1, 000 dollar genome. Genome Biol 7: 112.
36. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. 2000. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders. Science 287: 1265-1269.
37. Meyerson M, Gabriel S, Getz G. 2010. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11: 685-696.
38. Moore JH. 2010. Detecting, characterizing, and interpreting nonlinear gene-gene interactions using multifactor dimensionality reduction. Adv Genet 72: 101-116.
39. Nikitin A, Egorov S, Daraselia N, Mazo I. 2003. Pathway studio-the analysis and navigation of molecular networks. Bioinformatics 19: 2155-2157.
40. Ochs MF, Karchin R, Ressom H, Gentleman R. 2011. Identification of aberrant pathway and network activity from high-throughput data-workshop introduction. Pac Symp Biocomput 2011: 364-368.
41. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, et al. 2004. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600.
42. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. 2008. Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
43. Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, SurendranathV, Niranjan V, Muthusamy B, Gandhi TK, Gronborg M, et al. 2003. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 13: 2363-2371.
44. Pollack A. 2011. DNA sequencing caught in deluge of data. The New York Times, November 30.
45. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, et al. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
46. Qiu YQ, Zhang S, Zhang XS, Chen L. 2009. Identifying differentially expressed pathways via a mixed integer linear programming model. IET Syst Biol 3: 475-486.
47. Reich DE, Lander ES. 2001. On the allelic spectrum of human disease. Trends Genet 17: 502-510.
48. Ressom HW, Varghese RS, Zhang Z, Xuan J, Clarke R. 2008. Classification algorithms for phenotype prediction in genomics and proteomics. Front Biosci 13: 691-708.
49. Russ AP, Lampel S. 2005. The druggable genome: An update. Drug Discov Today 10: 1607-1610.
50. Sanger F, Air GM, Barrell BG, Brown NL, Coulson AR, Fiddes CA, Hutchison CA, Slocombe PM, Smith M. 1977. Nucleotide sequence of bacteriophage phi X174 DNA. Nature 265: 687-695.
51. Schadt EE. 2009. Molecular networks as sensors and drivers of common human diseases. Nature 461: 218-223.
52. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH. 2009. PID: The Pathway Interaction Database. Nucleic Acids Res 37: D674-D679.
53. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-RuizC, Lichtner P, Scholz SW, Hernandez DG, et al. 2009. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 15: 15.
54. Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N, SettlemanJ. 2009. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 15: 489-500.
55. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. 2010. Cytoscape 2. 8: New features for data integration and network visualization. Bioinformatics 27: 431-432.
56. Sun YV. 2010. Multigenic modeling of complex disease by random forests. Adv Genet 72: 73-99.
57. Tan CS, Bodenmiller B, Pasculescu A, Jovanovic M, Hengartner MO, JorgensenC, Bader GD, Aebersold R, Pawson T, Linding R. 2009. Comparative analysis reveals conserved protein phosphorylation networks implicated in multiple diseases. Sci Signal 2: ra39.
58. Tarca AL, Carey VJ, Chen XW, Romero R, Draghici S. 2007. Machine learning and its applications to biology. PLoS Comput Biol 3: e116.
59. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, PawsonT, Morris Q, Wrana JL. 2009. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 27: 199-204.
60. Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, Albanese A, Wood NW. 2001. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 68: 895-900.
61. Vaske CJ, Benz SC, Sanborn JZ, Earl D, Szeto C, Zhu J, Haussler D, Stuart JM. 2010. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 26: 237-245.
62. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, YandellM, Evans CA, Holt RA, et al. 2001. The sequence of the human genome. Science 291: 1304-1351.
63. Wang CC, Cirit M, Haugh JM. 2009. PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk. Mol Syst Biol 5: 246.
64. Wang J, Zhang Y, Marian C, Ressom HW. 2012. Identification of aberrant pathways and network activities from high-throughput data. Brief Bioinform doi: 10. 1093/bib/bbs001.
65. Wermuth CG, Ganellin CR, Lindberg P, Mitscher LA. 1998. Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998). Pure Appl Chem 70: 1129-1143.
66. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci 105: 5856-5861.
67. Wu G, Feng X, Stein L. 2010. A human functional protein interaction network and its application to cancer data analysis. Genome Biol 11: R53.
68. Yeger-Lotem E, Riva L, Su LJ, Gitler AD, Cashikar AG, King OD, Auluck PK, Geddie ML, Valastyan JS, Karger DR, et al. 2009. Bridging high-throughput genetic and transcriptional data reveals cellular responses to α-synuclein toxicity. Nat Genet 41: 316-323.
69. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, et al. 2010. PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2: 52ra73.
70. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, et al. 2004. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44: 601-607.